Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03EHR
|
||||
Former ID |
DIB002869
|
||||
Drug Name |
Lecimibide
|
||||
Synonyms |
DuP-128
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Terminated | [545142] | ||
Company |
Bristol-Myers Squibb Pharma Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C34H40F2N4OS
|
||||
Canonical SMILES |
c1(c([nH]c(n1)SCCCCCN(C(=O)Nc1c(cc(cc1)F)F)CCCCCCC)c1cc<br />ccc1)c1ccccc1
|
||||
CAS Number |
CAS 130804-35-2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Liver carboxylesterase | Target Info | Modulator | [533861] | |
KEGG Pathway | Drug metabolism - other enzymes | ||||
Metabolic pathways | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.